Iprindole
From Wikipedia, the free encyclopedia
|
Iprindole
|
|
| Systematic (IUPAC) name | |
| 3-(6,7,8,9,10,11-hexahydro-5H-cycloocta[b]
indol-5-yl)-N,N-dimethylpropan-1-amine |
|
| Identifiers | |
| CAS number | |
| ATC code | N06 |
| PubChem | |
| Chemical data | |
| Formula | C19H28N2 |
| Mol. mass | 284.439 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Iprindole (C19H28N2), a 5-HT2 antagonist, is a tricyclic antidepressant that can be fatal when combined with MDMA.
[edit] References
- The Merck Index, 12th Edition. 5091
[edit] External links
- Ganry H, Bourin M (1994). "[Iprindole: a functional link between serotonin and noradrenaline systems?]" (in French). L'Encéphale 20 (1): 7–11. PMID 8174513.
- Ganry H, Bourin M (1988). "Is iprindole an indirect betamimetic drug?". Neuropsychobiology 20 (4): 187–93. PMID 2908249.
|
|||||||||||||||||||||||||||||||

